Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$658 Mln
P/E Ratio
33.85
P/B Ratio
7.58
Industry P/E
--
Debt to Equity
0
ROE
0.24 %
ROCE
23.98 %
Div. Yield
1.34 %
Book Value
6.78
EPS
1.5
CFO
$81.25 Mln
EBITDA
$93.85 Mln
Net Profit
$73.94 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Iradimed Co (IRMD)
| -3.55 | 1.38 | -10.57 | 25.24 | 8.61 | 21.46 | 12.95 |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Iradimed Co (IRMD)
| 15.72 | 67.80 | -37.53 | 102.68 | -2.48 | -4.42 | 61.03 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.65 | 10,289.47 | 14.38 | 12.69 | |
| 72.28 | 9,544.04 | 92.52 | 2.52 | |
| 158.95 | 8,064.21 | -- | -25.23 | |
| 278.44 | 10,728.90 | 773.26 | 1.2 |
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers... MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida. Address: 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708 Read more
Founder, Chairman, CEO & President
Mr. Roger E. Susi
Founder, Chairman, CEO & President
Mr. Roger E. Susi
Headquarters
Winter Springs, FL
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Iradimed Co (IRMD) stood at $ 98 Mln as on 31-Dec-24
The share price of Iradimed Co (IRMD) is $53.05 (NASDAQ) as of 23-Apr-2025 14:36 EDT. Iradimed Co (IRMD) has given a return of 8.61% in the last 3 years.
Iradimed Co (IRMD) has a market capitalisation of $ 658 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Iradimed Co (IRMD) is 33.85 times as on 22-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Iradimed Co (IRMD) and enter the required number of quantities and click on buy to purchase the shares of Iradimed Co (IRMD).
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Winter Springs, Florida. Address: 1025 Willa Springs Drive, Winter Springs, FL, United States, 32708
The CEO & director of Mr. Roger E. Susi. is Iradimed Co (IRMD), and CFO & Sr. VP is Mr. Roger E. Susi.
There is no promoter pledging in Iradimed Co (IRMD).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Iradimed Co (IRMD) | Ratios |
|---|---|
|
Return on equity(%)
|
24.31
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
26.26
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Iradimed Co (IRMD) was $0 Mln.
$0.96
(
